Evidence map›Paper›PMID 29018808›Full record

ArticleFrontiers in veterinary science2017

Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses.

Charlotte Beerts, Marc Suls, Sarah Y Broeckx, Bert Seys, Aurélie Vandenberghe, Jeroen Declercq, Luc Duchateau, Martin A Vidal, Jan H Spaas

Open access · goldAbstract read
In one paragraph

Article in Frontiers in veterinary science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 58 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Current and Emerging Biologic Therapies for Equine Tendon and Ligament Injuries.The Veterinary clinics of North America. Equine practice · 2025
    Review
  6. Article
  7. Review
  8. Equine adipose-derived stem cells modulateFrontiers in veterinary science · 2025
    Article
  9. Review
  10. Article
  11. TLR4 knockdown by miRNA-140-5p improves tendinopathy: anArchives of medical science : AMS · 2024
    Article
  12. Article
  13. Review
  14. Review
  15. Viable tendon neotissue from adult adipose-derived multipotent stromal cells.Frontiers in bioengineering and biotechnology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Charlotte BeertsGlobal Stem Cell Technology, ANACURA Group, Evergem, Belgium.
Marc SulsEquine Veterinary Practice Dr. Suls, Nederweert, Netherlands.
Sarah Y BroeckxGlobal Stem Cell Technology, ANACURA Group, Evergem, Belgium.
Bert SeysEquine Veterinary Practice Dr. Suls, Nederweert, Netherlands.
Aurélie VandenbergheGlobal Stem Cell Technology, ANACURA Group, Evergem, Belgium.
Jeroen DeclercqVeterinary Practitioner, Oudenaarde, Belgium.
Luc DuchateauFaculty of Veterinary Medicine, Department of Comparative Physiology and Biometrics, Ghent University, Merelbeke, Belgium.
Martin A VidalCave Creek Equine Surgical & Imaging Center, Phoenix, AZ, United States.
Jan H SpaasGlobal Stem Cell Technology, ANACURA Group, Evergem, Belgium.
Ghent University · BEImaging Center · USON Semiconductor (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poor healing of tendon and ligament lesions often results in early retirement of sport horses. Therefore, regenerative therapies are being explored as potentially promising treatment for these injuries. In this study, an intralesional injection was performed with allogeneic tenogenically induced mesenchymal stem cells and platelet-rich plasma 5-6 days after diagnosis of suspensory ligament (SL) (

Indexed as

horseligamentmesenchymal stem cellsperipheral bloodtendontenogenic

Identifiers

PMID29018808
PMCPMC5622984
OpenAlexW2758565571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.